3rd Annual Hematologic Malignancies Symposium
How I Treat Elderly AML Patients in 2021: Does Midostaurin Improve OS in FLT3m Disease? Are DA+Cytarabine+/-GO Beneficial for EFS in Untreated Patients? Is CPX-351 Better Than SoC Chemo?
Comments 0
Login to view comments.
Click here to Login
